221 related articles for article (PubMed ID: 8386457)
1. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
[TBL] [Abstract][Full Text] [Related]
2. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
[TBL] [Abstract][Full Text] [Related]
3. Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo.
Schwieler JH; Kahan T; Nussberger J; Johansson MC; Hjemdahl P
Acta Physiol Scand; 1992 Aug; 145(4):333-43. PubMed ID: 1326853
[TBL] [Abstract][Full Text] [Related]
4. Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo.
Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):166-72. PubMed ID: 1648672
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
[TBL] [Abstract][Full Text] [Related]
6. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
Chauvin B; Richer C; Giudicelli JF
Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykinin.
Ruocco NA; Bergelson BA; Yu TK; Gavras I; Gavras H
Clin Exp Hypertens; 1995 Oct; 17(7):1059-72. PubMed ID: 8556004
[TBL] [Abstract][Full Text] [Related]
9. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.
Prescott MF; Webb RL; Reidy MA
Am J Pathol; 1991 Dec; 139(6):1291-6. PubMed ID: 1750504
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia.
Fabiani ME; Sourial M; Thomas WG; Johnston CI; Johnston CI; Frauman AG
J Endocrinol; 2001 Oct; 171(1):97-108. PubMed ID: 11572794
[TBL] [Abstract][Full Text] [Related]
12. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Farhy RD; Carretero OA; Ho KL; Scicli AG
Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
[TBL] [Abstract][Full Text] [Related]
16. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
Campbell DJ; Kladis A; Valentijn AJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
[TBL] [Abstract][Full Text] [Related]
17. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
18. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
Nap A; Balt JC; Pfaffendorf M; Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Heller J; Kramer HJ; Horácek V
Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
